Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...

Researchers have unveiled new AI tools, from smartphone cough analysis to child-friendly screening systems, which could ...

African scientists have developed a nanoscale drug delivery system to treat pericarditis, a drug-resistant and lethal ...

An individual within the Aegis Living retirement community in Issaquah was diagnosed with active tuberculosis on Monday.

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...

An international team of investigators today announced promising data from a trial of a novel antibiotic that could ...

Background: Tuberculosis (TB) is a major contributor to the global burden of disease and has received considerable attention in recent years, particularly in low- and middle-income countries where it ...

I am writing to bring attention to a pressing issue that demands our collective action and support: The plight of those affected by tuberculosis (TB) and the critical need for enhanced treatment ...

A new study published in PLOS Global Public Health contributes to the growing evidence that nutrition should be treated as a core part of tuberculosis care—not an afterthought. The research, conducted ...

The Food and Drug Administration approved a new tuberculosis medicine that shortens and improves treatment for the hardest-to-treat cases, a worsening problem in many poor countries. It's the first TB ...

Jiawan, D., Bansie, R., Chan, M., Thakoer, I. and Gopie, F.A. (2025) Necrotizing Sarcoid Granulomatosis with Concurrent ...